- Investing Ideas
- Global Pharmaceuticals & Biotech Leverage Leaders
Global Pharmaceuticals & Biotech Leverage Leaders
Results
222
222 companies
Ocular Therapeutix
Market Cap: US$2.1b
A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.
OCUL
US$9.64
7D
-1.2%
1Y
0.2%
Kardigan
Market Cap: US$2.2b
Operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases.
KARD
US$24.13
7D
6.9%
1Y
n/a
Laboratorios Farmaceuticos Rovi
Market Cap: €2.9b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€57.40
7D
-3.1%
1Y
3.1%
Crinetics Pharmaceuticals
Market Cap: US$4.1b
A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
CRNX
US$42.23
7D
20.7%
1Y
41.7%
Veradermics
Market Cap: US$5.4b
A clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions.
MANE
US$129.74
7D
8.7%
1Y
n/a
Dyne Therapeutics
Market Cap: US$3.6b
A clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.
DYN
US$23.07
7D
11.9%
1Y
163.4%